The KrasG12D;Trp53fl/fl murine model of undifferentiated pleomorphic sarcoma is macrophage dense, lymphocyte poor, and resistant to immune checkpoint blockade.
Sarcomas are rare, difficult to treat, mesenchymal lineage tumours that affect children and adults. Immunologically-based therapies have improved outcomes for numerous adult cancers, however, these therapeutic strategies have been minimally effective in sarcoma so far. Clinically relevant, immunolog...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0253864&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850239570341265408 |
|---|---|
| author | Karys M Hildebrand Arvind K Singla Reid McNeil Kayla L Marritt Kurt N Hildebrand Franz Zemp Jahanara Rajwani Doha Itani Pinaki Bose Douglas J Mahoney Frank R Jirik Michael J Monument |
| author_facet | Karys M Hildebrand Arvind K Singla Reid McNeil Kayla L Marritt Kurt N Hildebrand Franz Zemp Jahanara Rajwani Doha Itani Pinaki Bose Douglas J Mahoney Frank R Jirik Michael J Monument |
| author_sort | Karys M Hildebrand |
| collection | DOAJ |
| description | Sarcomas are rare, difficult to treat, mesenchymal lineage tumours that affect children and adults. Immunologically-based therapies have improved outcomes for numerous adult cancers, however, these therapeutic strategies have been minimally effective in sarcoma so far. Clinically relevant, immunologically-competent, and transplantable pre-clinical sarcoma models are essential to advance sarcoma immunology research. Herein we show that Cre-mediated activation of KrasG12D, and deletion of Trp53, in the hindlimb muscles of C57Bl/6 mice results in the highly penetrant, rapid onset undifferentiated pleomorphic sarcomas (UPS), one of the most common human sarcoma subtypes. Cell lines derived from spontaneous UPS tumours can be reproducibly transplanted into the hindlimbs or lungs of naïve, immune competent syngeneic mice. Immunological characterization of both spontaneous and transplanted UPS tumours demonstrates an immunologically-'quiescent' microenvironment, characterized by a paucity of lymphocytes, limited spontaneous adaptive immune pathways, and dense macrophage infiltrates. Macrophages are the dominant immune population in both spontaneous and transplanted UPS tumours, although compared to spontaneous tumours, transplanted tumours demonstrate increased spontaneous lymphocytic infiltrates. The growth of transplanted UPS tumours is unaffected by host lymphocyte deficiency, and despite strong expression of PD-1 on tumour infiltrating lymphocytes, tumours are resistant to immunological checkpoint blockade. This spontaneous and transplantable immune competent UPS model will be an important experimental tool in the pre-clinical development and evaluation of novel immunotherapeutic approaches for immunologically cold soft tissue sarcomas. |
| format | Article |
| id | doaj-art-2eb9820a225e40e79ee67a99c614faac |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-2eb9820a225e40e79ee67a99c614faac2025-08-20T02:01:06ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01167e025386410.1371/journal.pone.0253864The KrasG12D;Trp53fl/fl murine model of undifferentiated pleomorphic sarcoma is macrophage dense, lymphocyte poor, and resistant to immune checkpoint blockade.Karys M HildebrandArvind K SinglaReid McNeilKayla L MarrittKurt N HildebrandFranz ZempJahanara RajwaniDoha ItaniPinaki BoseDouglas J MahoneyFrank R JirikMichael J MonumentSarcomas are rare, difficult to treat, mesenchymal lineage tumours that affect children and adults. Immunologically-based therapies have improved outcomes for numerous adult cancers, however, these therapeutic strategies have been minimally effective in sarcoma so far. Clinically relevant, immunologically-competent, and transplantable pre-clinical sarcoma models are essential to advance sarcoma immunology research. Herein we show that Cre-mediated activation of KrasG12D, and deletion of Trp53, in the hindlimb muscles of C57Bl/6 mice results in the highly penetrant, rapid onset undifferentiated pleomorphic sarcomas (UPS), one of the most common human sarcoma subtypes. Cell lines derived from spontaneous UPS tumours can be reproducibly transplanted into the hindlimbs or lungs of naïve, immune competent syngeneic mice. Immunological characterization of both spontaneous and transplanted UPS tumours demonstrates an immunologically-'quiescent' microenvironment, characterized by a paucity of lymphocytes, limited spontaneous adaptive immune pathways, and dense macrophage infiltrates. Macrophages are the dominant immune population in both spontaneous and transplanted UPS tumours, although compared to spontaneous tumours, transplanted tumours demonstrate increased spontaneous lymphocytic infiltrates. The growth of transplanted UPS tumours is unaffected by host lymphocyte deficiency, and despite strong expression of PD-1 on tumour infiltrating lymphocytes, tumours are resistant to immunological checkpoint blockade. This spontaneous and transplantable immune competent UPS model will be an important experimental tool in the pre-clinical development and evaluation of novel immunotherapeutic approaches for immunologically cold soft tissue sarcomas.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0253864&type=printable |
| spellingShingle | Karys M Hildebrand Arvind K Singla Reid McNeil Kayla L Marritt Kurt N Hildebrand Franz Zemp Jahanara Rajwani Doha Itani Pinaki Bose Douglas J Mahoney Frank R Jirik Michael J Monument The KrasG12D;Trp53fl/fl murine model of undifferentiated pleomorphic sarcoma is macrophage dense, lymphocyte poor, and resistant to immune checkpoint blockade. PLoS ONE |
| title | The KrasG12D;Trp53fl/fl murine model of undifferentiated pleomorphic sarcoma is macrophage dense, lymphocyte poor, and resistant to immune checkpoint blockade. |
| title_full | The KrasG12D;Trp53fl/fl murine model of undifferentiated pleomorphic sarcoma is macrophage dense, lymphocyte poor, and resistant to immune checkpoint blockade. |
| title_fullStr | The KrasG12D;Trp53fl/fl murine model of undifferentiated pleomorphic sarcoma is macrophage dense, lymphocyte poor, and resistant to immune checkpoint blockade. |
| title_full_unstemmed | The KrasG12D;Trp53fl/fl murine model of undifferentiated pleomorphic sarcoma is macrophage dense, lymphocyte poor, and resistant to immune checkpoint blockade. |
| title_short | The KrasG12D;Trp53fl/fl murine model of undifferentiated pleomorphic sarcoma is macrophage dense, lymphocyte poor, and resistant to immune checkpoint blockade. |
| title_sort | krasg12d trp53fl fl murine model of undifferentiated pleomorphic sarcoma is macrophage dense lymphocyte poor and resistant to immune checkpoint blockade |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0253864&type=printable |
| work_keys_str_mv | AT karysmhildebrand thekrasg12dtrp53flflmurinemodelofundifferentiatedpleomorphicsarcomaismacrophagedenselymphocytepoorandresistanttoimmunecheckpointblockade AT arvindksingla thekrasg12dtrp53flflmurinemodelofundifferentiatedpleomorphicsarcomaismacrophagedenselymphocytepoorandresistanttoimmunecheckpointblockade AT reidmcneil thekrasg12dtrp53flflmurinemodelofundifferentiatedpleomorphicsarcomaismacrophagedenselymphocytepoorandresistanttoimmunecheckpointblockade AT kaylalmarritt thekrasg12dtrp53flflmurinemodelofundifferentiatedpleomorphicsarcomaismacrophagedenselymphocytepoorandresistanttoimmunecheckpointblockade AT kurtnhildebrand thekrasg12dtrp53flflmurinemodelofundifferentiatedpleomorphicsarcomaismacrophagedenselymphocytepoorandresistanttoimmunecheckpointblockade AT franzzemp thekrasg12dtrp53flflmurinemodelofundifferentiatedpleomorphicsarcomaismacrophagedenselymphocytepoorandresistanttoimmunecheckpointblockade AT jahanararajwani thekrasg12dtrp53flflmurinemodelofundifferentiatedpleomorphicsarcomaismacrophagedenselymphocytepoorandresistanttoimmunecheckpointblockade AT dohaitani thekrasg12dtrp53flflmurinemodelofundifferentiatedpleomorphicsarcomaismacrophagedenselymphocytepoorandresistanttoimmunecheckpointblockade AT pinakibose thekrasg12dtrp53flflmurinemodelofundifferentiatedpleomorphicsarcomaismacrophagedenselymphocytepoorandresistanttoimmunecheckpointblockade AT douglasjmahoney thekrasg12dtrp53flflmurinemodelofundifferentiatedpleomorphicsarcomaismacrophagedenselymphocytepoorandresistanttoimmunecheckpointblockade AT frankrjirik thekrasg12dtrp53flflmurinemodelofundifferentiatedpleomorphicsarcomaismacrophagedenselymphocytepoorandresistanttoimmunecheckpointblockade AT michaeljmonument thekrasg12dtrp53flflmurinemodelofundifferentiatedpleomorphicsarcomaismacrophagedenselymphocytepoorandresistanttoimmunecheckpointblockade AT karysmhildebrand krasg12dtrp53flflmurinemodelofundifferentiatedpleomorphicsarcomaismacrophagedenselymphocytepoorandresistanttoimmunecheckpointblockade AT arvindksingla krasg12dtrp53flflmurinemodelofundifferentiatedpleomorphicsarcomaismacrophagedenselymphocytepoorandresistanttoimmunecheckpointblockade AT reidmcneil krasg12dtrp53flflmurinemodelofundifferentiatedpleomorphicsarcomaismacrophagedenselymphocytepoorandresistanttoimmunecheckpointblockade AT kaylalmarritt krasg12dtrp53flflmurinemodelofundifferentiatedpleomorphicsarcomaismacrophagedenselymphocytepoorandresistanttoimmunecheckpointblockade AT kurtnhildebrand krasg12dtrp53flflmurinemodelofundifferentiatedpleomorphicsarcomaismacrophagedenselymphocytepoorandresistanttoimmunecheckpointblockade AT franzzemp krasg12dtrp53flflmurinemodelofundifferentiatedpleomorphicsarcomaismacrophagedenselymphocytepoorandresistanttoimmunecheckpointblockade AT jahanararajwani krasg12dtrp53flflmurinemodelofundifferentiatedpleomorphicsarcomaismacrophagedenselymphocytepoorandresistanttoimmunecheckpointblockade AT dohaitani krasg12dtrp53flflmurinemodelofundifferentiatedpleomorphicsarcomaismacrophagedenselymphocytepoorandresistanttoimmunecheckpointblockade AT pinakibose krasg12dtrp53flflmurinemodelofundifferentiatedpleomorphicsarcomaismacrophagedenselymphocytepoorandresistanttoimmunecheckpointblockade AT douglasjmahoney krasg12dtrp53flflmurinemodelofundifferentiatedpleomorphicsarcomaismacrophagedenselymphocytepoorandresistanttoimmunecheckpointblockade AT frankrjirik krasg12dtrp53flflmurinemodelofundifferentiatedpleomorphicsarcomaismacrophagedenselymphocytepoorandresistanttoimmunecheckpointblockade AT michaeljmonument krasg12dtrp53flflmurinemodelofundifferentiatedpleomorphicsarcomaismacrophagedenselymphocytepoorandresistanttoimmunecheckpointblockade |